Search

everythinglearnresearchcommunity

for

Search:↓

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Eating disorders are serious, often undiagnosed conditions requiring early treatment, with anorexia being the most deadly and binge-eating the most treatable.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

The document explains how male reproductive hormones work and affect the body.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.